S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

NGM Biopharmaceuticals Insider Trades

+0.31 (+2.29%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
270,948 shs
Average Volume
433,194 shs
Market Capitalization
$1.10 billion
P/E Ratio
Dividend Yield

NGM Biopharmaceuticals (NASDAQ:NGM) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Amount Of
Insider Buying
(Last 12 Months)
$3.03 M
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$2.27 M

Insider Buying and Selling by Quarter

Get NGM Insider Trade Alerts

Want to know when executives and insiders are buying or selling NGM Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NGM Biopharmaceuticals (NASDAQ:NGM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2022Group L P ColumnDirectorBuy89,049$13.42$1,195,037.581,336,461  
5/11/2022Group L P ColumnDirectorBuy83,175$11.25$935,718.751,012,753  
5/9/2022Group L P ColumnDirectorBuy83,175$10.79$897,458.25902,090  
12/6/2021Jin-Long ChenInsiderSell15,000$18.21$273,150.00  
11/18/2021David J WoodhouseCEOSell15,000$20.02$300,300.00  
11/15/2021Jin-Long ChenInsiderSell30,000$19.73$591,900.00  
10/11/2021Jin-Long ChenInsiderSell15,000$20.41$306,150.00  
10/5/2021Hsiao D LieuSVPSell2,000$22.00$44,000.00  
9/13/2021Jin-Long ChenInsiderSell15,000$26.03$390,450.00  
8/9/2021Jin-Long ChenInsiderSell15,000$24.46$366,900.00  
4/12/2021Jin-Long ChenInsiderSell25,000$24.65$616,250.00945,005  
3/1/2021Jin-Long ChenInsiderSell25,000$26.66$666,500.00970,005  
1/4/2021Jin-Long ChenInsiderSell25,000$29.28$732,000.00870,375  
12/14/2020Jin-Long ChenInsiderSell25,000$28.01$700,250.00908,879  
10/12/2020Jin-Long ChenInsiderSell25,000$17.02$425,500.00945,005  
9/1/2020Group L P ColumnDirectorBuy36,494$17.64$643,754.16  
9/1/2020Jin-Long ChenInsiderSell25,000$17.83$445,750.00977,618  
8/27/2020Group L P ColumnDirectorBuy36,359$17.79$646,826.61  
8/24/2020Group L P ColumnDirectorBuy11,024$17.96$197,991.04  
8/21/2020Group L P ColumnDirectorBuy7,321$17.97$131,558.37  
8/17/2020Group L P ColumnDirectorBuy6,425$17.89$114,943.25  
8/13/2020Group L P ColumnDirectorBuy19,895$17.89$355,921.55  
7/30/2020Group L P ColumnDirectorBuy732$17.99$13,168.68  
7/27/2020Group L P ColumnDirectorBuy3,834$17.99$68,973.66  
7/24/2020Group L P ColumnDirectorBuy68,749$17.93$1,232,669.57  
7/22/2020Group L P ColumnDirectorBuy193$18.00$3,474.00  
7/1/2020Jin-Long ChenInsiderSell25,000$18.91$472,750.001,027,268  
6/15/2020Jin-Long ChenInsiderSell25,000$21.65$541,250.00  
5/15/2020Hsiao D. LieuSVPSell1,562$22.00$34,364.00  
4/7/2020Group L P ColumnMajor ShareholderBuy138,315$14.19$1,962,689.85  
4/7/2020Peter SvennilsonDirectorBuy123,728$14.38$1,779,208.6420,000  
4/2/2020Group L P ColumnMajor ShareholderBuy250,984$12.78$3,207,575.52  
4/2/2020Peter SvennilsonDirectorBuy14,850$12.40$184,140.0020,000  
3/31/2020Peter SvennilsonDirectorBuy118,067$12.53$1,479,379.5120,000  
3/25/2020Group L P ColumnMajor ShareholderBuy301,180$13.33$4,014,729.40  
3/25/2020Peter SvennilsonDirectorBuy2,416$12.49$30,175.8420,000  
3/23/2020Peter SvennilsonDirectorBuy170,387$11.63$1,981,600.8120,000  
3/20/2020Group L P ColumnMajor ShareholderBuy143,082$11.77$1,684,075.14  
3/19/2020Peter SvennilsonDirectorBuy148,464$11.59$1,720,697.7620,000  
3/5/2020Peter SvennilsonDirectorBuy8,307$18.00$149,526.0020,000  
3/4/2020Group L P ColumnMajor ShareholderBuy9,986$17.96$179,348.56  
3/3/2020Peter SvennilsonDirectorBuy38,758$17.99$697,256.4220,000  
3/2/2020Group L P ColumnMajor ShareholderBuy14,124$17.90$252,819.60  
2/28/2020Group L P ColumnMajor ShareholderBuy75,447$18.04$1,361,063.88  
2/27/2020Peter SvennilsonDirectorBuy33,896$17.91$607,077.3620,000  
2/26/2020Group L P ColumnMajor ShareholderBuy3,751$18.00$67,518.00  
2/6/2020Group L P ColumnMajor ShareholderBuy44,900$15.47$694,603.00  
1/9/2020Jin-Long ChenInsiderSell18,641$17.95$334,605.951,012,783  
1/7/2020Jin-Long ChenInsiderSell16,090$18.20$292,838.001,012,783  
11/11/2019Peter SvennilsonDirectorBuy15$12.00$180.0020,000  
11/4/2019Jin-Long ChenInsiderSell50,765$12.67$643,192.55
11/4/2019Peter SvennilsonDirectorBuy8,409$13.01$109,401.09
10/23/2019Peter SvennilsonDirectorBuy4,387$13.54$59,399.98
10/21/2019Group L P ColumnMajor ShareholderSell30,926$77.72$2,403,568.72
10/21/2019Peter SvennilsonDirectorBuy84,939$11.75$998,033.25
10/16/2019David V GoeddelDirectorBuy11,000$3.10$34,100.00
10/16/2019Group L P ColumnMajor ShareholderBuy103,000$10.87$1,119,610.00
10/14/2019Group L P ColumnMajor ShareholderSell20,000$1.41$28,200.00
10/11/2019Group L P ColumnMajor ShareholderBuy53,172$10.38$551,925.36
8/9/2019Group L P ColumnMajor ShareholderBuy224,664$14.00$3,145,296.00  
8/6/2019David V GoeddelDirectorBuy6,134$13.98$85,753.32  
8/2/2019Group L P ColumnMajor ShareholderBuy4,382$13.98$61,260.36  
7/30/2019Peter SvennilsonDirectorBuy28,056$13.68$383,806.08  
7/26/2019David V GoeddelDirectorBuy89,866$13.49$1,212,292.34  
7/23/2019Group L P ColumnMajor ShareholderBuy67,742$13.49$913,839.58  
7/16/2019Group L P ColumnMajor ShareholderBuy20,088$13.72$275,607.36  
7/12/2019Group L P ColumnMajor ShareholderBuy31,884$13.88$442,549.92  
6/24/2019Group L P ColumnMajor ShareholderBuy12,240$13.78$168,667.20  
6/21/2019Group L P ColumnMajor ShareholderBuy34,377$13.90$477,840.30  
6/14/2019Peter SvennilsonDirectorBuy29,760$14.05$418,128.00  
6/11/2019Group L P ColumnMajor ShareholderBuy23,500$13.74$322,890.00  
6/6/2019Group L P ColumnMajor ShareholderBuy25,200$13.40$337,680.00  
5/20/2019Group L P ColumnMajor ShareholderBuy50,000$13.50$675,000.00  
5/10/2019Group L P ColumnMajor ShareholderBuy17,923$13.85$248,233.55  
5/7/2019Peter SvennilsonDirectorBuy57,000$14.10$803,700.00  
4/8/2019Merck & Co., Inc.Major ShareholderBuy4,121,683$16.00$65,946,928.00  
4/8/2019Suzanne Sawochka HooperDirectorBuy7,000$16.00$112,000.00  
(Data available from 1/1/2013 forward)

NGM Biopharmaceuticals (NASDAQ:NGM) Insider Trade Frequently Asked Questions

Who is on NGM Biopharmaceuticals's Insider Roster?

The list of insiders at NGM Biopharmaceuticals includes David J Woodhouse, David V Goeddel, Group L P Column, Hsiao D Lieu, Jin-Long Chen, and Peter Svennilson. Learn more on insiders at NGM.

What percentage of NGM Biopharmaceuticals stock is owned by insiders?

38.10% of NGM Biopharmaceuticals stock is owned by insiders. Learn more on NGM's insider holdings.

Which NGM Biopharmaceuticals insiders have been buying company stock?

The following insider purchased NGM Biopharmaceuticals stock in the last 24 months: Group L P Column ($6,437,495.47).

How much insider buying is happening at NGM Biopharmaceuticals?

Insiders have purchased a total of 446,425 NGM Biopharmaceuticals shares in the last 24 months for a total of $6,437,495.47 bought.

Which NGM Biopharmaceuticals insiders have been selling company stock?

The following insiders have sold NGM Biopharmaceuticals stock in the last 24 months: David J Woodhouse ($300,300.00), Hsiao D Lieu ($44,000.00), and Jin-Long Chen ($6,528,800.00).

How much insider selling is happening at NGM Biopharmaceuticals?

Insiders have sold a total of 307,000 NGM Biopharmaceuticals shares in the last 24 months for a total of $6,873,100.00 sold.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.